A new update to Pharmaceutical Substances was released on July 28, 2005. The new release includes 7 new active pharmaceutical ingredients and a new synthetic process for the API Azacitidine.
Bortezomib | Duloxetine oxalate | Erlotinib hydrochloride | Fosamprenavir | Lumiracoxib | Rimonabant | Ximelagatran |
|
